Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration ...

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.

The liver has a unique structure, especially at the level of individual cells. Hepatocytes, the main liver cells, release ...

A team of researchers at Baylor College of Medicine, UMass Chan Medical School and Cincinnati Children's Hospital Medical ...

Intellia Therapeutics shares fell 25% amid safety concerns in Phase 3 trials. Check out if today's selloff in NTLA stock is a ...

Non-alcoholic steatohepatitis (NASH), a severe form of fatty liver disease, is projected to become the leading cause of liver ...

Intellia reports a grade 4 liver enzyme elevation in a Nex-Z trial patient; no hospitalization is required, and enrollment ...

The liver has a unique structure, especially at the level of individual cells. Hepatocytes, the main liver cells, release ...

Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.

Medical pros revisit the 150-year history of coffee enemas to weigh their potential benefits and hidden dangers.

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Two pediatricians urge California education leaders to take further steps to lower added sugar limits in school meals.